Method for separation purification of polymyxin B1 from polymyxin B mixed component

A technology of polymyxin and mixed components, which is applied in the field of medicine and can solve the problems of high equipment requirements, poor separation effect, and difficulty in large-scale preparation.

Inactive Publication Date: 2014-07-16
SHANGHAI INST OF PHARMA IND CO LTD +1
View PDF5 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0010] Polymyxin B1 is the most important component of polymyxin B. The literature reports on the separation and purification method of polymyxin B1 are as follows: W. Hausmann et al. components, but the separation effect is relatively poor (see W.Hausmann et al., Polymyxin B1.1Fractionation, Molecular Weight Determination, AminoAcid and Fatty Acid Composition.Journal of the American Chemicalsociety, 1954, 76(19):4892-4896); H. Kalasz et al. used displacement chromatography, using the analytical chromatographic column LiChrosorb RP-18 (5 μm, 250 × 4.6mm I.D.) as the stationary phase to separate B1 and B2, but only trace amounts of polymyxin B1 could be prepared (see H.Kalasz et al., Prepare-scale separation of polymyxins with an analytical high-performance liquid chromatography system by using displacement chromatography. Journal of Chromatography A, 1981, 251: 295-302); Y.Kimura et al. used Hitachi gel 3010 (granule 25 μm in diameter) and Amberlite XAD-2 (100-200 mesh) as filler, and linear gradient elution was used to effectively separate B1 and B2 (see Y.Kimura et al., Analytical and preparative methods for polymyxinantibiotics using high-performance liquid chromatography with a porous styrene-divinyllbenzene copolymer packing.Journal of ChromatographyA, 1981, 206: 563-572); I.Elverdam et al. used a reverse silica gel column LiChrosorb Si100ODS (10μm, 250×40mm I.D.), with isocratic elution method, for polyviscosity The single component of mycocin B was isolated (see I.Elverdam et al., Isolation and characterization of three newpolymyxins in polymyxins B and E by high-performance liquid chromatography.Journal of Chromatography A, 1981, 218: 653-661); He Fengyun in China also used reverse phase silica gel YMC C18-ODS-A (C18 bonded silica gel, 5μm, 150mm ×30mm) preparative column, with acetonitrile / water (21 / 79, V / V) containing 0.1% trifluoroacetic acid as mobile phase, to prepare polymyxin B1, but its single batch preparation amount is also low, the average per The sample load per milliliter of filler is 1.1 mg (see He Fengyun et al. Research on the preparation method of polymyxin B1 in polymyxin B. Chemical Times, 2011, 25(8): 20-22)
[0011] The separation and purification of polymyxin B1 by the above method has the following disadvantages: the separation effect is poor when using the countercurrent distribution method; High equipment requirements, poor stability of the separation medium, less repeated use times, and high cost
In short, the above methods are not easy to scale up

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for separation purification of polymyxin B1 from polymyxin B mixed component
  • Method for separation purification of polymyxin B1 from polymyxin B mixed component
  • Method for separation purification of polymyxin B1 from polymyxin B mixed component

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Take polymyxin B sulfate sample, add water to dissolve and configure 50mg / ml aqueous solution.

[0031] Pack PS30-300 (Suzhou Nan Microbe Technology Co., Ltd., particle size of 30 μm) chromatography column bed 30ml, after equilibrating 3 times column volume with acidic aqueous solution (formic acid to adjust pH2.3) containing 8% acetonitrile (V / V), Get a 10ml sample and put it on the column, and then elute it with an acidic aqueous solution containing 8% acetonitrile (formic acid adjusts the pH to 2.3). The purity of colistin B1 was 99.2%, and the yield was 63%.

Embodiment 2

[0033] Take polymyxin B sulfate sample, add water to dissolve and configure 10mg / ml aqueous solution.

[0034]Pack 30ml of PS25-300 (Suzhou Nan Microbe Technology Co., Ltd., particle size 25μm) chromatography column bed, equilibrate 3 times column volume with acidic aqueous solution containing 9% acetonitrile (adjust pH 2.0 with formic acid), take 30ml sample and put it on the column , and then eluted with an acidic aqueous solution containing 9% acetonitrile (formic acid to adjust the pH to 2.0). After the eluate was analyzed by HPLC, the part of the polymyxin B1 peak purity greater than 98% was collected, and the obtained polymyxin B1 had a purity of It was 99.5%, and the yield was 60%.

Embodiment 3

[0036] Take polymyxin B sulfate sample, add water to dissolve and configure 100mg / ml aqueous solution.

[0037] Install 30ml of PS30-300 chromatography column bed, equilibrate 3 times column volume with acidic aqueous solution containing 15% ethanol (adjust pH 2.3 with formic acid), take 3ml sample on the column, and then use acidic solution containing 15% ethanol (V / V) Aqueous solution (formic acid adjusted to pH 2.3) was eluted, and after the eluate was analyzed by HPLC, the part of polymyxin B 1 peak purity greater than 98% was collected, and the obtained polymyxin B 1 had a purity of 98.6% and a yield of 45% %.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

The present invention provides a method for separation purification of polymyxin B1 from a polymyxin B mixed component. The method comprises: (a) loading a chromatography medium of a macroporous absorption resin to obtain a chromatography column; and (b) adding a polymyxin B solution, and adopting an organic solvent-containing acid solution as an eluent to sequentially elute various components of the polymyxin B so as to obtain the polymyxin B1 solution after elution. According to the method, the operation is simple, the adopted separation medium has characteristics of stable chemical characteristic and high re-use rate, industrial scale-up is easily achieved, and the peak purity of the obtained polymyxin B1 can be more than 98%.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a method for separating and purifying single-component polymyxin B1 from mixed components of polymyxin B. Background technique [0002] Polymyxin B (polymyxin B, whose general structural formula is shown in the following formula I) is a basic cyclic polypeptide antibiotic composed of various amino acids and fatty acids produced by Bacillus polymyxa. The medicinal form of polymyxin B is polymyxin B sulfate and its compound preparation with other drugs. It is mainly used as an anti-infective drug clinically to treat infections caused by Gram-negative bacteria such as Pseudomonas aeruginosa. Infections in skin wounds, urinary system, eyes, ears, trachea, etc. can also be used for sepsis, peritonitis, etc. Polymyxin B is a multi-component mixture with similar structure. Seven components have been found, namely B1, B1-I, B2, B3, B4, B5 and B6 (see formula 1 for the gener...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/62C07K1/22
Inventor 侯静品赵文杰赵波那可魏晓东杨筱静徐加兵许炜刘永双马川川
Owner SHANGHAI INST OF PHARMA IND CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products